Showing results (131-140 of 139) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Leukemia|April 11, 2019
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemiaDaniel A Pollyea, Martin S Tallman, Stéphane de Botton, et al.The Lancet. Haematology|March 9, 2020
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trialEytan M Stein, Amir T Fathi, Courtney D DiNardo, et al.Translational Psychiatry|April 13, 2016
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasmaJ M Coughlin, Y Wang, E B Ambinder, et al.Diabetes, Obesity & Metabolism|November 23, 2012
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetesS J Yang, K W Min, S K Gupta, et al.Leukemia|June 6, 2017
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemiaS Tharkar-Promod, D P Johnson, S E Bennett, et al.Journal of Viral Hepatitis|April 14, 2006
Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*N Bräu, E J Bini, S Currie, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
Atomically accurate de novo design of antibodies with RFdiffusionNathaniel R Bennett, Joseph L Watson, Robert J Ragotte, et al.Nature|November 5, 2025
Atomically accurate de novo design of antibodies with RFdiffusionNathaniel R Bennett, Joseph L Watson, Robert J Ragotte, et al.World Journal of Emergency Surgery : WJES|August 9, 2017
Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)M Sartelli, D G Weber, E Ruppé, et al.Pageof 14